top of page

Biopharma Daily Stock Updates - 01/12/21

Updated: Jan 13, 2021

$XBI $149.35 (+0.87%) 📈


COVID:

$MRNA (+6.22%) - Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland


PIPELINE:


$MIRM (+5.04%) - News Release Details Mirum Pharmaceuticals Provides Corporate Update


$TVTX (+1.07%) - Travere Therapeutics Announces Orphan Drug Designation for Sparsentan for the Treatment of IgA Nephropathy


$MRUS (+20.30%) - Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium


$OTLK (-1.59%) - Leading Ophthalmology Organization Launches Podcast Video with Firas Rahhal, MD, to Explore the Genesis and Promise of Outlook Therapeutics’ ONS-5010/LYTENAVA™ (bevacizumab-vikg)


FINANCIAL:

$MNOV (+0.54%) - MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners


$CERC (+8.87%) - Closed offering priced at $2.60/share


$RGNX (+1.27%) - Closed offering priced at $47/share


$RDHL (-13.66%) - RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million


0 comments

Comments


bottom of page